ATE169219T1 - Behandlung von katarakt mit 15-keto- prostaglandinderivaten - Google Patents
Behandlung von katarakt mit 15-keto- prostaglandinderivatenInfo
- Publication number
- ATE169219T1 ATE169219T1 AT91302925T AT91302925T ATE169219T1 AT E169219 T1 ATE169219 T1 AT E169219T1 AT 91302925 T AT91302925 T AT 91302925T AT 91302925 T AT91302925 T AT 91302925T AT E169219 T1 ATE169219 T1 AT E169219T1
- Authority
- AT
- Austria
- Prior art keywords
- cataract
- treatment
- inderivatives
- prostagland
- keto
- Prior art date
Links
- 208000002177 Cataract Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9089590 | 1990-04-04 | ||
JP22164690 | 1990-08-22 | ||
JP2931091 | 1991-01-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE169219T1 true ATE169219T1 (de) | 1998-08-15 |
Family
ID=27286510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91302925T ATE169219T1 (de) | 1990-04-04 | 1991-04-03 | Behandlung von katarakt mit 15-keto- prostaglandinderivaten |
Country Status (11)
Country | Link |
---|---|
US (2) | US5212324A (de) |
EP (1) | EP0453127B1 (de) |
KR (1) | KR970005172B1 (de) |
AT (1) | ATE169219T1 (de) |
AU (1) | AU644148B2 (de) |
CA (1) | CA2039420C (de) |
DE (1) | DE69129921T2 (de) |
DK (1) | DK0453127T3 (de) |
ES (1) | ES2119762T3 (de) |
GR (1) | GR3027666T3 (de) |
TW (2) | TW249226B (de) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW205508B (de) * | 1990-08-02 | 1993-05-11 | Kabushikaisha Ueno Seiyaku Oyo Kenkyujo | |
US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US5688819A (en) * | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US5972991A (en) | 1992-09-21 | 1999-10-26 | Allergan | Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
US5328933A (en) * | 1992-10-28 | 1994-07-12 | Allergan, Inc. | Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues |
SE9303627D0 (sv) * | 1993-11-03 | 1993-11-03 | Kabi Pharmacia Ab | Method and means for prevention of cataract |
EP0735895B1 (de) * | 1993-11-19 | 2006-01-18 | The University Of Sydney | Verfahren zur prophylaxe oder kontrolle des katarakts |
SE9403160D0 (sv) * | 1994-09-21 | 1994-09-21 | Pharmacia Ab | Method and means for prevention and treatment of secondary cataract |
CN102126998B (zh) * | 1996-06-10 | 2013-06-12 | 苏坎波公司 | 内皮素拮抗剂 |
SK3372000A3 (en) * | 1997-09-09 | 2000-10-09 | Procter & Gamble | A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders |
NZ503738A (en) * | 1997-09-09 | 2001-05-25 | Procter & Gamble | Aromatic C16-20-substituted tetrahydro prostaglandin F analogues useful as FP agonists |
CN1206997C (zh) * | 1997-11-28 | 2005-06-22 | 株式会社·R-技术上野 | 内皮缩血管肽拮抗剂 |
KR20010108316A (ko) | 1999-03-05 | 2001-12-07 | 데이비드 엠 모이어 | C16 불포화된 fp-선택적 프로스타글란딘 유사체 |
TWI225398B (en) | 1999-07-14 | 2004-12-21 | R Tech Ueno Ltd | Composition for treatment of external secretion disorders |
US6458836B1 (en) | 2000-03-16 | 2002-10-01 | Sucampo, A.G. | Treatment of ocular hypertension and glaucoma |
RU2002127733A (ru) * | 2000-03-16 | 2004-03-27 | Сукампо Аг (Ch) | Способ лечения или профилактики повышенного глазного давления и глаукомы, фармацевтическая композиция и способ получения соединения простагландинов |
CA2403086C (en) | 2000-03-24 | 2010-08-17 | Sucampo Ag | Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof |
US20020172693A1 (en) * | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020013294A1 (en) * | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020146439A1 (en) * | 2000-03-31 | 2002-10-10 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
MXPA02009915A (es) | 2000-04-06 | 2003-03-27 | Sucampo Ag | Composicion promotora de secrecion de bilis. |
TWI302100B (en) | 2001-05-02 | 2008-10-21 | Sucampo Ag | Composition for treating drug-induced constipation |
KR20040029012A (ko) * | 2001-08-23 | 2004-04-03 | 수캄포 아게 | 안내압항진 및 녹내장 치료용 방법 및 조성물 |
EP1420794B1 (de) | 2001-08-31 | 2017-12-27 | Sucampo AG | Prostaglandin-analoga als chloridkanalöffner |
US8580851B2 (en) | 2002-08-21 | 2013-11-12 | Sucampo Ag | Ophthalmic solution |
US8114911B2 (en) * | 2002-10-23 | 2012-02-14 | Sucampo Ag | Prostaglandin compounds for the treatment of obesity |
KR101164838B1 (ko) | 2002-12-27 | 2012-07-11 | 수캄포 아게 | 복부 불쾌감 치료용 프로스타글랜딘의 유도체 |
EP1641462B1 (de) * | 2003-07-03 | 2010-11-24 | Sucampo AG | Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner |
TWI495471B (zh) * | 2003-08-12 | 2015-08-11 | R Tech Ueno Ltd | 促進毛髮生長之組成物及方法 |
KR101118935B1 (ko) | 2003-08-21 | 2012-03-13 | 가부시키가이샤 아루떼꾸 우에노 | 안과용 조성물 |
SE0303179D0 (sv) * | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
US7321057B2 (en) * | 2004-08-02 | 2008-01-22 | R-Tech Ueno, Ltd. | Method for manufacturing prostaglandin analogue |
AR055846A1 (es) | 2005-01-27 | 2007-09-12 | Sucampo Ag | Compuesto de prostaglandina y metodo para tratar trastornos del sistema nervioso central |
KR20160120809A (ko) | 2005-03-04 | 2016-10-18 | 수캄포 아게 | 말초 혈관 질환 치료를 위한 방법 및 조성물 |
US9241918B2 (en) | 2005-03-16 | 2016-01-26 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
US7851504B2 (en) | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
US20060281818A1 (en) | 2005-03-21 | 2006-12-14 | Sucampo Ag, North Carolina State University | Method for treating mucosal disorders |
JP5711442B2 (ja) * | 2005-04-12 | 2015-04-30 | スキャンポ・アーゲーSucampo AG | 胃腸障害の処置のためのプロスタグランジン化合物およびプロトンポンプ阻害剤の併用 |
US7985770B2 (en) | 2006-01-24 | 2011-07-26 | Sucampo Ag | Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
US8026393B2 (en) | 2006-01-24 | 2011-09-27 | Sucampo Ag | Soft-gelatin capsule formulation |
CN101400354B (zh) * | 2006-03-13 | 2014-10-22 | 株式会社·R-技术上野 | 水性组合物 |
US8871752B2 (en) | 2008-02-19 | 2014-10-28 | Sucampo Ag | Method for modulating stem cell growth |
US8722739B2 (en) * | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8609729B2 (en) * | 2009-04-15 | 2013-12-17 | Sucampo Ag | Method for treating macular degeneration |
US8569279B2 (en) * | 2009-05-27 | 2013-10-29 | Sucampo Ag | Method for modulating claudin mediated functions |
US9084815B2 (en) * | 2009-09-16 | 2015-07-21 | Sucampo Ag | Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor |
US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
KR20140035363A (ko) | 2011-04-07 | 2014-03-21 | 수캄포 아게 | 안정피로 치료 방법 |
EP2739278A4 (de) | 2011-08-05 | 2015-03-18 | Sucampo Ag | Verfahren zur behandlung von schizophrenie |
AR092821A1 (es) | 2012-04-20 | 2015-05-06 | Sucampo Ag | Conjugado de derivado de acido graso-polimero |
US20150057351A1 (en) | 2013-08-22 | 2015-02-26 | Sucampo Ag | Method for treating neuropathic pain |
AR105029A1 (es) | 2015-06-19 | 2017-08-30 | Sucampo Ag | Composición farmacéutica que comprende derivado de ácido graso |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3505386A (en) * | 1965-12-29 | 1970-04-07 | Upjohn Co | Compounds related to prostaglandins |
US3974195A (en) * | 1974-10-02 | 1976-08-10 | The Upjohn Company | 2A,2B-Dihomo-15-alkyl-PGF2.sub.α analogs |
EP0153858A3 (de) * | 1984-02-29 | 1985-12-11 | The Upjohn Company | Therapeutische Anwendung von Protaglandinen |
CA1323364C (en) * | 1987-01-28 | 1993-10-19 | Ryuzo Ueno | Prostaglandins e and anti ulcer agents containing same |
CA1322749C (en) * | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
CA1324129C (en) * | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
ES2038289T3 (es) * | 1987-05-15 | 1993-07-16 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal. |
DE3876050T2 (de) * | 1987-09-18 | 1993-03-25 | R Tech Ueno Ltd | Okulare hypotensivagenzien. |
DE3873007T2 (de) * | 1987-10-02 | 1992-12-03 | Ueno Seiyaku Oyo Kenkyujo Kk | Kathartica. |
JP2597629B2 (ja) * | 1988-02-26 | 1997-04-09 | 株式会社 上野製薬応用研究所 | 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化 |
JP2597649B2 (ja) * | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
AU619543B2 (en) * | 1988-05-11 | 1992-01-30 | Sucampo Ag | Use of 15-ketoprostaglandin e or f compounds for uterine contraction |
EP0343904B1 (de) * | 1988-05-23 | 1993-04-28 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Hypersphyxia verursachende Zusammensetzung |
AU604156B2 (en) * | 1988-09-14 | 1990-12-06 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
ATE162074T1 (de) * | 1988-10-01 | 1998-01-15 | R Tech Ueno Ltd | Oculare hypotensive mittel |
TW205508B (de) * | 1990-08-02 | 1993-05-11 | Kabushikaisha Ueno Seiyaku Oyo Kenkyujo |
-
1991
- 1991-03-28 TW TW081106617A patent/TW249226B/zh not_active IP Right Cessation
- 1991-03-28 CA CA002039420A patent/CA2039420C/en not_active Expired - Lifetime
- 1991-03-28 TW TW080102419A patent/TW224942B/zh not_active IP Right Cessation
- 1991-04-03 AU AU74047/91A patent/AU644148B2/en not_active Expired
- 1991-04-03 DK DK91302925T patent/DK0453127T3/da active
- 1991-04-03 AT AT91302925T patent/ATE169219T1/de not_active IP Right Cessation
- 1991-04-03 EP EP91302925A patent/EP0453127B1/de not_active Expired - Lifetime
- 1991-04-03 US US07/680,187 patent/US5212324A/en not_active Expired - Lifetime
- 1991-04-03 DE DE69129921T patent/DE69129921T2/de not_active Expired - Lifetime
- 1991-04-03 ES ES91302925T patent/ES2119762T3/es not_active Expired - Lifetime
- 1991-04-04 KR KR1019910005502A patent/KR970005172B1/ko not_active IP Right Cessation
-
1994
- 1994-09-06 US US08/300,541 patent/US5686487A/en not_active Expired - Lifetime
-
1998
- 1998-08-19 GR GR980400874T patent/GR3027666T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69129921T2 (de) | 1999-01-14 |
DK0453127T3 (da) | 1998-10-26 |
EP0453127B1 (de) | 1998-08-05 |
KR910018027A (ko) | 1991-11-30 |
US5212324A (en) | 1993-05-18 |
TW224942B (de) | 1994-06-11 |
ES2119762T3 (es) | 1998-10-16 |
CA2039420C (en) | 1996-12-10 |
AU7404791A (en) | 1991-10-10 |
EP0453127A3 (en) | 1992-12-09 |
CA2039420A1 (en) | 1991-10-05 |
AU644148B2 (en) | 1993-12-02 |
GR3027666T3 (en) | 1998-11-30 |
DE69129921D1 (de) | 1998-09-10 |
US5686487A (en) | 1997-11-11 |
EP0453127A2 (de) | 1991-10-23 |
KR970005172B1 (ko) | 1997-04-14 |
TW249226B (de) | 1995-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE169219T1 (de) | Behandlung von katarakt mit 15-keto- prostaglandinderivaten | |
DE69130586T2 (de) | Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten | |
DE69213057D1 (de) | Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen | |
ATE137116T1 (de) | Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen | |
ATE132749T1 (de) | Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten | |
DE69032000D1 (de) | Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten | |
ATE129895T1 (de) | Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten. | |
DE69123892T2 (de) | Behandlung von Katarakt mit prostacyclinverbindungen | |
DE69124415D1 (de) | Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen | |
DK0458537T3 (da) | Anvendelse af en terapeutisk forbindelse til behandling af bronkitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |